Trial Outcomes & Findings for Miromatrix Biological Mesh for Hiatal Hernia Repair (NCT NCT02436681)

NCT ID: NCT02436681

Last Updated: 2019-09-20

Results Overview

Failure of the index hernia operation which requires another operative procedure to correct. Hernia recurrence was assessed with a barium upper gastrointestinal series or in some cases other imaging analysis to characterize the anatomy of the esophagus.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

2 years

Results posted on

2019-09-20

Participant Flow

Subjects were recruited from treating surgeon's normal practice.

3 found to be ineligible (inclusion/exclusion) at surgery 2 Withdrew consent prior to surgery 2 Mesh not implanted per surgeon discretion 2 Canceled procedure

Participant milestones

Participant milestones
Measure
MIROMESH
MIROMESH was used for laparoscopic paraesophageal hernia repair
Overall Study
STARTED
41
Overall Study
COMPLETED
27
Overall Study
NOT COMPLETED
14

Reasons for withdrawal

Reasons for withdrawal
Measure
MIROMESH
MIROMESH was used for laparoscopic paraesophageal hernia repair
Overall Study
Lost to Follow-up
10
Overall Study
Withdrawal by Subject
2
Overall Study
Death
2

Baseline Characteristics

Miromatrix Biological Mesh for Hiatal Hernia Repair

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
MIROMESH
n=41 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
Age, Continuous
63.3 years
STANDARD_DEVIATION 12.5 • n=5 Participants
Sex: Female, Male
Female
34 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
40 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
41 participants
n=5 Participants
ASA Status
1 - Healthy Patients
1 Participants
n=5 Participants
ASA Status
2 - Mild to moderate systemic disease, controlled
23 Participants
n=5 Participants
ASA Status
3 - Severe disease process, limited activity
14 Participants
n=5 Participants
ASA Status
Unknown
3 Participants
n=5 Participants
BMI
30.7 kg/m^2
STANDARD_DEVIATION 4.0 • n=5 Participants
Smoking Status
Current
1 Participants
n=5 Participants
Smoking Status
Ex-smoker
11 Participants
n=5 Participants
Smoking Status
Never
29 Participants
n=5 Participants
Gastroesophageal Reflux Disease Health Related Quality of Life (GERD-HRQL)
19.3 Score
STANDARD_DEVIATION 13.5 • n=5 Participants
GERD-HRQL Global Assessment
Satisfied
7 Participants
n=5 Participants
GERD-HRQL Global Assessment
Neutral
3 Participants
n=5 Participants
GERD-HRQL Global Assessment
Dissatisfied
29 Participants
n=5 Participants
GERD-HRQL Global Assessment
Unknown
2 Participants
n=5 Participants
SF36 - Physical Component Summary Score
41.5 Score
STANDARD_DEVIATION 9.9 • n=5 Participants
SF36 - Mental Component Summary Score
46.6 Score
STANDARD_DEVIATION 12.0 • n=5 Participants
SF36 - Physical Functioning
38.9 Score
STANDARD_DEVIATION 9.5 • n=5 Participants
SF36 - Social Functioning
42.5 Score
STANDARD_DEVIATION 10.7 • n=5 Participants

PRIMARY outcome

Timeframe: 2 years

Population: Lost to follow up 10 Withdrew Consent 2 Death 2

Failure of the index hernia operation which requires another operative procedure to correct. Hernia recurrence was assessed with a barium upper gastrointestinal series or in some cases other imaging analysis to characterize the anatomy of the esophagus.

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
Number of Subjects With a Hernia Recurrence Requiring Reoperation
0 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Population: Lost to follow up 10 Withdrew Consent 2 Death 2

Reports the number of radiographic recurrence of hernia that does not require surgery and are generally asymptomatic. Hernia recurrence was assessed with a barium upper gastrointestinal series or in some cases other imaging analysis to characterize the anatomy of the esophagus.

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
Radiographic Recurrence
3 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Population: Lost to follow up 10 Withdrew Consent 2 Death 2

The Gastroesophageal Reflux Disease Health Related Quality of Life (GERD-HRQL) scale assess on symptoms associated with gastroesophageal reflux disease. There are 10 questions (each representing a GERD symptom such as heartburn) answered on a 6-point scale of 0 - 6 with 0 indicating no symptoms and 5 indicating incapacitating symptoms. The answer to all questions are summed to give you a final score on the scale. Scores may range for 0 (no symptoms) to 50 (incapacitating symptoms).

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
GERD-HRQL
3.8 Score
Standard Deviation 5.3

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Population: Lost to follow up 10 Withdrew Consent 2 Death 2

Same as baseline

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
GERD-HRQL Global Assessment
Satisfied
23 Participants
GERD-HRQL Global Assessment
Neutral
2 Participants
GERD-HRQL Global Assessment
Dissatisfied
1 Participants
GERD-HRQL Global Assessment
Unknown
1 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Population: Lost to follow up 10 Withdrew Consent 2 Death 2

Measure Description: The Short-Form 36 (SF-36) is a general health assessment tool comprised of 8 sub-scales including Physical Function, Role Physical, Bodily Pain, and General health which assess aspects of physical health. These are used to make an overall physical health score, the Physical Component Summary score (PCS). The higher the score the better the subject's physical health. Range from 0-100.

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
SF36 - Physical Component Summary Score
47.2 Score
Standard Deviation 9.3

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Measure Description: The Short-Form 36 (SF-36) is a general health assessment tool comprised of 8 sub-scales including Vitality, Role Emotional, Social Functioning, and Mental health which assess aspects of Mental health. These are used to make an overall mental health score, the Mental Component Summary score (MCS). The higher the score the better the subject's mental health. Range from 0-100.

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
SF36 - Mental Component Summary Score
53.6 Score
Standard Deviation 8.0

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Population: Same as baseline

Measure Description: The Short-Form 36 (SF-36) is a general health assessment tool comprised of 8 sub-scales including Physical Functioning which assess aspects of physical health. The higher the score the better the subject's physical health. Range from 0-100.

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
SF36 - Physical Functioning
45.6 Score
Standard Deviation 10.6

OTHER_PRE_SPECIFIED outcome

Timeframe: 2 years

Measure Description: The Short-Form 36 (SF-36) is a general health assessment tool comprised of 8 sub-scales including Social Functioning which assess aspects of mental health. The higher the score the better the subject's physical health. Range from 0-100.

Outcome measures

Outcome measures
Measure
MIROMESH
n=27 Participants
MIROMESH was used for laparoscopic paraesophageal hernia repair
SF36 - Social Functioning
49.5 Score
Standard Deviation 8.8

Adverse Events

MIROMESH

Serious events: 2 serious events
Other events: 10 other events
Deaths: 2 deaths

Serious adverse events

Serious adverse events
Measure
MIROMESH
n=41 participants at risk
MIROMESH was used for laparoscopic paraesophageal hernia repair
Respiratory, thoracic and mediastinal disorders
Acute respiratory distress
2.4%
1/41 • Number of events 2 • 2 years post procedure
Gastrointestinal disorders
Nausea/vomiting
2.4%
1/41 • Number of events 1 • 2 years post procedure

Other adverse events

Other adverse events
Measure
MIROMESH
n=41 participants at risk
MIROMESH was used for laparoscopic paraesophageal hernia repair
Gastrointestinal disorders
Abdominal Pain
2.4%
1/41 • Number of events 1 • 2 years post procedure
Gastrointestinal disorders
Diarrhea
2.4%
1/41 • Number of events 1 • 2 years post procedure
Gastrointestinal disorders
Dysphagia
2.4%
1/41 • Number of events 1 • 2 years post procedure
Gastrointestinal disorders
Edema at GE Junction
4.9%
2/41 • Number of events 2 • 2 years post procedure
Gastrointestinal disorders
Food Bolus Obstruction
2.4%
1/41 • Number of events 1 • 2 years post procedure
Gastrointestinal disorders
Acute Gastric Distension
2.4%
1/41 • Number of events 1 • 2 years post procedure
Gastrointestinal disorders
Anterior Gastropexy Pain
2.4%
1/41 • Number of events 1 • 2 years post procedure
Blood and lymphatic system disorders
Mild Hypoxia
2.4%
1/41 • Number of events 1 • 2 years post procedure
Gastrointestinal disorders
Nausea and Vomiting
4.9%
2/41 • Number of events 2 • 2 years post procedure
General disorders
Pleural Effusion requiring drainage
2.4%
1/41 • Number of events 1 • 2 years post procedure
General disorders
Soreness
2.4%
1/41 • Number of events 1 • 2 years post procedure
Renal and urinary disorders
Urinary Tract Infection
2.4%
1/41 • Number of events 1 • 2 years post procedure

Additional Information

Head of Clinical Affairs

Miromatrix

Phone: 952.942-6000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place